Hematology and Oncology
Home Hematology and Oncology
Daily Low-Dose Aspirin May Reduce Risk of Some Cancers
Effect was seen most strongly with colon, gastrointestinal tumors
Women Often Overestimate Odds of Early Breast Cancer Spreading
Misperceptions lead to worry that harms quality of life, researcher says
High Mole Count Doesn’t Always Indicate Higher Melanoma Risk
Physicians shouldn't rely on mole count as the only reason to perform skin exams
Ovarian CA Encompasses More Than One Kind of Malignancy
Better understanding needed to improve prevention, detection, treatment, U.S. panel notes
Spouse Education Level May Impact Choice for Rural Practice
Lower odds of working in rural HPSA for physicians married to a highly-educated spouse
Type 1 Diabetes Linked to Increased Risk of Certain Cancers
Study suggests that odds increase for some types of tumors, but drop for others
FDA: Guidance to Help Prevent Donor-Related Zika Infection
Part of FDA's ongoing efforts to protect HCT/Ps and blood products from Zika virus transmission
SCOTUS: States Can’t Force Health Care Data Release
Supreme Court rules states can't force health insurers to turn over data
PRAME Predicts Metastasis in Class 1 Uveal Melanoma
PRAME mRNA expression is independent prognostic biomarker in Class 1 uveal melanoma
February 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2016. This roundup includes...
